Loading the company…
Loading the company…
Families: Tumor & fibroid embolization.
All companies · Product and company coverage
In the last ten years FDA made 2 decisions for Suzhou Haowei Medical Technology (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2026 (1). The latest was on 2026-07-31.
| Family | Decisions on record |
|---|---|
| Tumor & fibroid embolization | 2 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-07-31 | 510(k) | K252812 | UniPearls® Embolic Microspheres |
| 2023-11-14 | 510(k) | K231554 | UniPearls® Embolic Microspheres |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Suzhou Haowei Medical Technology.